Allergan, Inc. (AGN)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2525 DUPONT DRIVE IRVINE, CA 92612

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company operates in two segments: specialty pharmaceuticals and medical devices. The Company discovers, develops and commercializes a diverse range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries.

Are you looking for this stock instead?

View SEC Filings from AGN instead.

View recent insider trading info

Funds Holding AGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TERMEER HENRI A

  • Director
No longer subject to file 2015-03-17 0

PYOTT DAVID E I CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
No longer subject to file 2015-03-17 0

GALLAGHER MICHAEL R

  • Director
No longer subject to file 2015-03-17 0

BARLOW JAMES F SR. VP, CORP. CONTROLLER (PAO)

  • Officer
No longer subject to file 2015-03-17 0

INGRAM DOUGLAS S PRESIDENT

  • Officer
No longer subject to file 2015-03-17 0

LAVIGNE LOUIS J JR

  • Director
No longer subject to file 2015-03-17 0

RAY RUSSELL T

  • Director
No longer subject to file 2015-03-17 0

JONES TREVOR M

  • Director
No longer subject to file 2015-03-17 0

WHITCUP SCOTT M EXECUTIVE VP, R&D, CSO

  • Officer
No longer subject to file 2015-03-17 0

DUNSIRE DEBORAH

  • Director
No longer subject to file 2015-03-17 0

PINKSTON ARNOLD A EVP AND GENERAL COUNSEL

  • Officer
No longer subject to file 2015-03-17 0

DIRADOORIAN RAYMOND H EVPGLOBAL TECHNICAL OPERATIONS

  • Officer
No longer subject to file 2015-03-17 0

PROCTOR TIMOTHY D

  • Director
No longer subject to file 2015-03-17 0

SHERMAN SCOTT D EXECUTIVE VICE PRESIDENT, HR

  • Officer
No longer subject to file 2015-03-17 0

GANGOLLI JULIAN S CVP & PRES, NORTH AMERICA

  • Officer
No longer subject to file 2015-03-17 0

MCDONNELL PETER J

  • Director
No longer subject to file 2015-03-17 0

HINDMAN JAMES M. EVP, FINANCE & BUS. DEV., CFO

  • Officer
No longer subject to file 2015-03-17 0

EDWARDS JEFFREY L EVP, FIN & BUS. DEV., CFO

  • Officer
0 2014-02-21 0

HUDSON DAWN E

  • Director
11,600 2014-02-19 0

ENDICOTT DAVID J. CVP AND PRESIDENT, AGN MED

  • Officer
No longer subject to file 2013-07-09 0

BOYER HERBERT W PH D

  • Director
No longer subject to file 2013-04-29 0

RYAN STEPHEN J

  • Director
No longer subject to file 2013-03-21 0

INGRAM ROBERT ALEXANDER

  • Director
0 2012-10-29 0

HERBERT GAVIN S

  • Director
214,760 2011-05-02 0

BALL F MICHAEL PRESIDENT

  • Officer
39,305 2011-03-22 0

SCHAEFFER LEONARD D

  • FORMER DIRECTOR/RETIRED 5/3/11
No longer subject to file 2011-03-14 0

GESTEN SAMUEL J EVP, GEN. COUNSEL & ASST. SEC.

  • Officer
2,285 2011-02-17 0

DYER-BRUGGEMAN DIANNE EVP, HUMAN RESOURCES

  • Officer
10,178 2010-02-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments